CA Patent

CA2176298C — A single high dose fluoroquinolone treatment

Assigned to Bayer Corp · Expires 2009-01-27 · 17y expired

What this patent protects

The present invention relates to treatment of animals with fluoroquinolones. More specifically, the present invention relates to the use of fluoroqunolones in a single high dose to replace multiple lower doses.

USPTO Abstract

The present invention relates to treatment of animals with fluoroquinolones. More specifically, the present invention relates to the use of fluoroqunolones in a single high dose to replace multiple lower doses.

Drugs covered by this patent

Alphagan (BRIMONIDINE TARTRATE) · Senju Pharmaceutical Co., Ltd

Patent Metadata

Patent number: CA2176298C
Jurisdiction: CA
Classification: —
Expires: 2009-01-27
Drug substance claim: No
Drug product claim: No
Assignee: Bayer Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.